leukaemia / lymphoma Flashcards

(42 cards)

1
Q

most common childhood cancer

A

ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

most common type of ALL

A

B-ALL (85%)
T-ALL (15%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

peak age of ALL presentation

A

2-5y

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

4 syndromes a/w ALL

A

a. Down syndrome
b. NF1
c. Bloom syndrome
d. Ataxia telangiectasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

biggest prognostic factor for ALL

A

response to induction!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ALL: favourable vs not favourable genetics

A

favourable:
1. Hyperdiploidy (>50)
2. Trisomies 4, 10
3. ETV-RUNX protein (t12;21)

not favourable:
1. Hypodiploidy (<44)
2. Philadelphia t(9;22)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

achieving remission after end of induction measured by?

A

MRD - must be <0.01% by D29

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ALL risk factors

A

i. Age > 10y or <1y
ii. WCC > 50 or CSF/testicular involvement at diagnosis
iii. Cytogenetic/molecular
iv. Response to induction – biggest prognostic factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

for FRACP, DIC + leukaemia = what kind?

A

APML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

very specific FRACP features for AML

A
  1. Subcutaneous nodules – ‘blueberry muffin’ lesions
  2. Infiltration of gingiva
  3. DIC (APML**)
  4. Discrete masses – chloromas, granulocytic sarcomas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

bone marrow findings of ALL vs AML

A

ALL 85% blasts, high nucleus:cytoplasm ratio

AML 20% blasts, with auer rods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe the mutation in APML, and therefore its treatment

A

t15;17 = PML-RARA: responsive to all-trans-retinoic acid (ATRA, tretinoin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

survival rate of ALL vs AML

A

ALL: up to 99% with favourable genetics, say 90%

AML: 60-70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

down syndrome: AML or ALL?

A

ALL: 20x more common EXCEPT in first 3 years of life
- worse cytogenetics, worse prognosis
- T21 more sensitive to MTX

AML: better survival in T21!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

why are FBEs important in T21 neonates?

A

10% get transient leukaemia/MPD (high leuks, blasts, low plt/Hb)

and 20-30% will develop leukaemia by 3y

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

bcr-abl: what’s the mutation and Rx

A

t(9;22) > imatinib TK inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

JMML syndromic risk factors

A
  1. noonan’s
  2. NF1
18
Q

most JMML have mutations in what pathway?

A

RAS/MAP kinase pathway

19
Q

key features of JMML

A
  • 1/3rd present with an URTI with hepatosplenomegaly and a rash
  • *monocytosis *
20
Q

most cases of infant leukaemia (<1y) from what mutation?

A

> 80% MLL gene (11q23 band translocation; majority t(14;11)) - and this is a shit one

21
Q

HLH: most common age group

22
Q

pathogenesis of HLH

A

trigger > abnormal immune activation: macrophages eat up RBC and make cytokine storm, but NK and CD8 T cells can’t shut the macrophages down

23
Q

most familial HLH is caused by what kind of problem?

A

defect in perforin, so NK/CD8 can’t do their job against the macrophages

24
Q

aetiology of HLH

A
  1. genetic mutation
  2. infection - EBV**
  3. malignancy - esp lymphoid
  4. macrophage activation syndrome e.g. JIA/other rheum
25
symptoms of HLH
1. fever *** 2. rash - macpap or petechiae 3. hepsplen 4. lymphadenopathy 5. resp distress 6. CNS signs ... so very non-specific really
26
key Ix of HLH
1. cytopaenia (Hb, plt, neuts) 2. high ferritin 3. high TG 4. hepatitis
27
worst prognostic factor for HLH
higher ferritin
28
clinical presentation of lymphomas vs leukaemia
lymphomas less constitutional symptoms (H 1/3, NHL 10%). More often have regional lymphadenopathy
29
concerning areas for lympahdenopathy
non-cervical and **supravlacivular**
30
types of lymphoma
HL vs NHL (DLBCL, lymphoblastic lymphoma, burkitt's, ALCL)
31
presence of B symptoms matters for which cancer
HL (NOT NHL)
32
classic biopsy finding of HL
Reed-Sternberg...but also seen in EBV!
33
HL vs NHL
HL: spread continguously, rarely extra-nodal. prognosis BETTER NHL: non-contiguous spread, often extra-nodal e.g. skin, GI
34
epidemiology of HL - ages and sex
M:F 3 to 1 rare <5, peak 15-35y
35
lymphoma and SOB - what to think of?
mediastinal mass (bulky >1/3 of diameter) > obstruction / SVC compression, dangerous for GA
36
5-year OS for HD of all stages is...?
> 80%
37
favourable prognostic factors for HL
<10 yo, female, favourable subtypes (LP and NS) and Stage I non-bulky disease
38
poor prognostic factors with a HL relapse
<1y from completion of tx B symptoms extra-nodal
39
which is more common in children - HL or NHL
NHL 60%, esp Burkitt's younger, DLBCL adolescents
40
BL vs DLBCL
BL - highly aggressive. germinal centre B cells. mainly abdo primary, (jaw for africans) with bone / CNS mets. "starry sky" appearance. **TLS** DLBCL - aggressive. mature B cell. mainly mediastinal /abdo primary, RARELY with bone/CNS mets. TLS UNCOMMON
41
types of Burkitt's
endemic = African, jaw, younger, upstream of c-myc, CNS > BMA, a/w EBV sporadic = worldwide, abdo primary, a bit older (~11y), at c-myc, BMA > CNS, no EBV
42
survival rate of PTLD
20-35%